Scholarlink

Background <p>Cerebral malaria (CM) is a subcategory of severe malaria (SM) and a major cause of death in <i>Plasmodium falciparum</i> infections, driven by the sequestration of infected red blood cells in the microvasculature of host vital organs. Identifying early biomarkers of CM is crucial for timely intervention. This study assessed the potential of microRNAs, produced upon organ injury, as biomarkers of CM.</p> Methods <p>Plasma levels of six microRNAs were quantified in patients with CM (<i>n</i> = 43), severe non-CM (SNCM; <i>n</i> = 50), uncomplicated malaria (UM; <i>n</i> = 79), asymptomatic malaria (AM; <i>n</i> = 80), and non-malarial febrile illnesses (nMFI; <i>n</i> = 69) using TaqMan-RT-qPCR.</p> Results <p>Plasma levels of hsa-miR-21-5p, hsa-miR-150-5p, and hsa-miR-3158-3p correlated with SM (<i>p</i> &lt; 0.0005) and CM patients (<i>p</i> &lt; 0.0005), as determined by the Mann–Whitney U test and logistic regression models, with a study power of &gt; 80%. A random forest machine learning (ML) model predicted CM patients on admission using a combination of three microRNA levels, achieving 83% sensitivity, 100% specificity, and 92% balanced accuracy.</p> Conclusions <p>The combined use of hsa-miR-21-5p, hsa-miR-150-5p, and hsa-miR-3158-3p microRNAs may offer a powerful, non-invasive approach for early CM diagnosis, potentially improving clinical outcomes and patient survival.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Potential of microRNAs as diagnostic markers for distinguishing malaria severity in samples from an Indian cohort

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年8月25日

查看全文
  • Aditi Gupta,
  • Kushagri Arora,
  • Sneha Bhandari,
  • Ruhi Sikka,
  • Samuel C. Wassmer,
  • Praveen Kumar Bharti,
  • Himanshu Gupta

摘要

Background

Cerebral malaria (CM) is a subcategory of severe malaria (SM) and a major cause of death in Plasmodium falciparum infections, driven by the sequestration of infected red blood cells in the microvasculature of host vital organs. Identifying early biomarkers of CM is crucial for timely intervention. This study assessed the potential of microRNAs, produced upon organ injury, as biomarkers of CM.

Methods

Plasma levels of six microRNAs were quantified in patients with CM (n = 43), severe non-CM (SNCM; n = 50), uncomplicated malaria (UM; n = 79), asymptomatic malaria (AM; n = 80), and non-malarial febrile illnesses (nMFI; n = 69) using TaqMan-RT-qPCR.

Results

Plasma levels of hsa-miR-21-5p, hsa-miR-150-5p, and hsa-miR-3158-3p correlated with SM (p < 0.0005) and CM patients (p < 0.0005), as determined by the Mann–Whitney U test and logistic regression models, with a study power of > 80%. A random forest machine learning (ML) model predicted CM patients on admission using a combination of three microRNA levels, achieving 83% sensitivity, 100% specificity, and 92% balanced accuracy.

Conclusions

The combined use of hsa-miR-21-5p, hsa-miR-150-5p, and hsa-miR-3158-3p microRNAs may offer a powerful, non-invasive approach for early CM diagnosis, potentially improving clinical outcomes and patient survival.